12/18
10:44 am
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Truist Financial Co. from $240.00 to $285.00. They now have a "buy" rating on the stock.
Medium
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Truist Financial Co. from $240.00 to $285.00. They now have a "buy" rating on the stock.
12/17
08:15 am
pen
Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $275.00 price target on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $275.00 price target on the stock.
12/11
02:44 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Citigroup Inc. from $220.00 to $245.00. They now have a "neutral" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Citigroup Inc. from $220.00 to $245.00. They now have a "neutral" rating on the stock.
12/11
08:00 am
pen
Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $275.00 price target on the stock, up previously from $190.00.
Medium
Report
Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $275.00 price target on the stock, up previously from $190.00.
12/9
12:54 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $260.00 to $323.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $260.00 to $323.00. They now have a "buy" rating on the stock.
12/6
10:57 am
pen
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term [Yahoo! Finance]
12/4
07:26 am
pen
Investing in Penumbra (NYSE:PEN) five years ago would have delivered you a 55% gain [Yahoo! Finance]
Low
Report
Investing in Penumbra (NYSE:PEN) five years ago would have delivered you a 55% gain [Yahoo! Finance]
11/29
01:00 pm
pen
Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report? [Yahoo! Finance]
Neutral
Report
Why Is Penumbra (PEN) Up 6.7% Since Last Earnings Report? [Yahoo! Finance]
11/26
12:29 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $232.00 to $270.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $232.00 to $270.00. They now have a "buy" rating on the stock.
11/26
12:03 pm
pen
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
11/20
04:30 pm
pen
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
Low
Report
Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
11/20
01:16 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $235.00 to $250.00. They now have an "overweight" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $235.00 to $250.00. They now have an "overweight" rating on the stock.
11/20
11:12 am
pen
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
Low
Report
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]
11/5
11:04 am
pen
Here's Why Penumbra (PEN) is a Strong Momentum Stock [Yahoo! Finance]
Low
Report
Here's Why Penumbra (PEN) is a Strong Momentum Stock [Yahoo! Finance]
11/5
09:00 am
pen
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
Low
Report
New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
11/4
12:48 pm
pen
Implied Volatility Surging for Penumbra (PEN) Stock Options [Yahoo! Finance]
Low
Report
Implied Volatility Surging for Penumbra (PEN) Stock Options [Yahoo! Finance]
11/4
11:43 am
pen
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
10/31
09:45 pm
pen
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market [Yahoo! Finance Canada]
Medium
Report
Penumbra Q3 Earnings Beat, Margins Expand, Stock Up in After Market [Yahoo! Finance Canada]
10/31
02:35 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $225.00 to $235.00. They now have an "overweight" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Piper Sandler from $225.00 to $235.00. They now have an "overweight" rating on the stock.
10/31
08:35 am
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Robert W. Baird from $244.00 to $248.00. They now have an "outperform" rating on the stock.
Medium
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Robert W. Baird from $244.00 to $248.00. They now have an "outperform" rating on the stock.
10/30
04:05 pm
pen
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
Medium
Report
Penumbra, Inc. Reports Third Quarter 2024 Financial Results
10/25
08:37 am
pen
Penumbra, Inc. (NYSE: PEN) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
10/18
10:34 am
pen
Penumbra, Inc. (NYSE: PEN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $225.00 price target on the stock, up previously from $200.00.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $225.00 price target on the stock, up previously from $200.00.
10/16
02:34 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $176.00 to $235.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $176.00 to $235.00. They now have a "buy" rating on the stock.
10/14
01:44 pm
pen
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $224.00 to $234.00. They now have a "buy" rating on the stock.
Low
Report
Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at BTIG Research from $224.00 to $234.00. They now have a "buy" rating on the stock.